HATFIELD HEALTH CENTRE — All Prescriptions & Medications
Practice Code: C86003 | DONCASTER, DN7 6JH
Over the last 12 months, HATFIELD HEALTH CENTRE prescribed 264,693 items across 644 different medications at a total cost of £2,062,975 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Telmisartan with diuretic | 10 | 280 | £78 | -11.5% ▼ |
| Dexamfetamine sulfate | 10 | 280 | £215 | -72.2% ▼ |
| Vigabatrin | 10 | 1,500 | £738 | -8.1% ▼ |
| Erythromycin ethylsuccinate | 10 | 1,200 | £101 | -57.2% ▼ |
| Fosfomycin trometamol | 10 | 12 | £56 | -64.9% ▼ |
| Saxagliptin | 10 | 280 | £300 | -70.1% ▼ |
| Cabergoline | 10 | 88 | £153 | -35.5% ▼ |
| Indoramin | 10 | 600 | £491 | -34.2% ▼ |
| Triptorelin acetate | 10 | 10 | £690 | -30.2% ▼ |
| Powder preterm infant formula (0913111) | 10 | 25.6K | £388 | -37.2% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 10 | 23.9K | £1.6K | -62.4% ▼ |
| Betamethasone sodium phosphate | 10 | 100 | £22 | -61.4% ▼ |
| Fludroxycortide | 10 | 10 | £197 | -5.2% ▼ |
| Cocois | 10 | 1,000 | £146 | -27.2% ▼ |
| Co-cyprindiol (Cyprote acetate/ethinylestradiol) | 10 | 567 | £76 | +15.3% ▲ |
| Permethrin | 10 | 600 | £171 | -73.5% ▼ |
| 10 | 105 | £321 | +59.0% ▲ | |
| 10 | 240 | £485 | -74.6% ▼ | |
| 10 | 600 | £816 | +2.2% ▲ | |
| 10 | 10 | £178 | +16.4% ▲ | |
| 10 | 300 | £519 | -32.7% ▼ | |
| 10 | 12 | £105 | +168.0% ▲ | |
| 10 | 10 | £121 | +13.0% ▲ | |
| 10 | 330 | £820 | -34.4% ▼ | |
| 10 | 390 | £507 | -38.7% ▼ | |
| Balsalazide sodium | 11 | 1,412 | £314 | -26.1% ▼ |
| Labetalol hydrochloride | 11 | 560 | £86 | -51.6% ▼ |
| Lisinopril with diuretic | 11 | 308 | £81 | -46.4% ▼ |
| Formoterol fumarate | 11 | 11 | £248 | -23.3% ▼ |
| Ethosuximide | 11 | 1,232 | £2.7K | -25.4% ▼ |
| Oestrogens conjugated | 11 | 700 | £262 | -46.1% ▼ |
| Tube feed 1 kcal/ml peptide based (0914041) | 11 | 405.0K | £7.7K | +23.8% ▲ |
| Diclofenac potassium | 11 | 438 | £75 | +204.0% ▲ |
| 11 | 146 | £196 | +0.5% vs avg | |
| 11 | 12 | £936 | +10.3% ▲ | |
| 11 | 1,575 | £232 | -72.0% ▼ | |
| 11 | 215 | £955 | -27.7% ▼ | |
| 11 | 535 | £1.1K | -32.1% ▼ | |
| Nizatidine | 12 | 676 | £331 | -65.1% ▼ |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 12 | 336 | £193 | -24.1% ▼ |
| Terbutaline sulphate | 12 | 51 | £109 | -77.9% ▼ |
| Acrivastine | 12 | 1,008 | £295 | -2.6% ▼ |
| Alimemazine tartrate | 12 | 1,200 | £1.1K | -7.2% ▼ |
| Tube feed 1.5 kcal/ml (0914011) | 12 | 490.0K | £8.2K | +22.6% ▲ |
| Tube feed 1 kcal/ml peptide based (0914032) | 12 | 436.5K | £10.3K | +34.5% ▲ |
| Dantrolene sodium | 12 | 5,389 | £865 | -33.5% ▼ |
| 12 | 12 | £443 | +198.0% ▲ | |
| 12 | 360 | £330 | -70.4% ▼ | |
| 12 | 600 | £4.2K | -5.3% ▼ | |
| Cimetidine | 13 | 3,900 | £177 | -30.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.